Regulatory PathRegulatory requirements compared

Active substances

Nicotinamide + Pyridoxine + Riboflavin + Thiamine

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade nameStrengthForm · routePackPublic priceTypeCompanyStatus
BECOVIT SYRUPSyrup · Oral use1 BottleSAR 6.90Generic · OTCGulf Pharmaceutical Industries (Julphar)Withdrawn by MAH · Not Marketed
BECOVIT TABLETTablet · Oral use30 BlisterSAR 7.85Generic · OTCGulf Pharmaceutical Industries (Julphar)Withdrawn by MAH · Not Marketed
BECOZYM FORTE TABTablet · Oral use20 BlisterSAR 12.30Generic · OTCROCHEWithdrawn by MAH · Not Marketed
BECOZYM SYRUP 100 ML.Syrup · Oral use1 BottleSAR 16.40NCE · PrescriptionROCHEWithdrawn by MAH · Not Marketed
BENEXOL 12 TABTablet · Oral use10 BlisterSAR 8.75Generic · PrescriptionROCHEWithdrawn by MAH · Not Marketed
DAGRAVIT B-COMPLEX TABTablet · Oral use50 BlisterSAR 5.65Generic · OTCDAGRAWithdrawn by regulatory authority · Not Marketed
POLYBION DROPSOral drops, solution · Oral use1 Dropper ContainerSAR 5.10Generic · OTCMerck Healthcare KGaAWithdrawn by MAH · Not Marketed
SURBEX FILM TABTablet · Oral use25 BlisterSAR 6.75Generic · OTCAbbott LaboratoriesWithdrawn by MAH · Not Marketed

Components

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.